Press Releases

LTS Lohmann Therapie-Systeme AG (LTS), a market leader in transdermal therapeutic systems, and LEO Pharma A/S, a global leader in dermatology, today announced that the companies will start the clinical trial of microarray patches for the local intradermal treatment of psoriasis.

EsoCap AG and LTS Lohmann Therapy-Systeme AG announced the start of cooperation on industrial development of a unique drug delivery technology for diseases of the upper gastrointestinal tract.

In January members of the Association, along with Dr. Torsten Baehner, head physician of the Anaesthesia and IC unit at St. Nikolaus-Stift Hospital, displayed the trolley for Ulrich Sielaff, member of the board at LTS.

LTS announced today that Dr. Tim G. Schlange, member of the LTS management board and CMO of LTS, will present at the J.P. Morgan 35th Annual Healthcare Conference 2017.